Geron
No bio yet
This person is not in any teams
This person is not in any offices
Geron
4 followers
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.